MP01-11 POOLED ANALYSIS OF BLADDER FUNCTION POST-AQUABLATION

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology I (MP01)1 Sep 2021MP01-11 POOLED ANALYSIS OF BLADDER FUNCTION POST-AQUABLATION Dean Elterman, Peter Gilling, Claus Roehrborn, Neil Barber, Vincent Misrai, Kevin C. Zorn, Naeem Bhojani, Alexis E. Te, Mitch Humphreys, Steven Kaplan, Mihir Desai, and Thorsten Bach Dean EltermanDean Elterman More articles by this author , Peter GillingPeter Gilling More articles by this author , Claus RoehrbornClaus Roehrborn More articles by this author , Neil BarberNeil Barber More articles by this author , Vincent MisraiVincent Misrai More articles by this author , Kevin C. ZornKevin C. Zorn More articles by this author , Naeem BhojaniNaeem Bhojani More articles by this author , Alexis E. TeAlexis E. Te More articles by this author , Mitch HumphreysMitch Humphreys More articles by this author , Steven KaplanSteven Kaplan More articles by this author , Mihir DesaiMihir Desai More articles by this author , and Thorsten BachThorsten Bach More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001962.11AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Aquablation Therapy (AQUABEAM Robotic System, PROCEPT BioRobotics, Inc., USA) is an ultrasound-guided, robotically executed waterjet ablative procedure used to treat men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). It has demonstrated treatment in a wide range of prostate sizes while minimizing irreversible complications (erectile dysfunction, ejaculatory dysfunction, incontinence). This analysis explores the bladder function following Aquablation in various prostate volume and anatomical subgroups. METHODS: Four prospective, global, clinical studies have been conducted with Aquablation with a minimum follow up of one year; WATER, WATER II, FRANCAIS WATER, and OPEN WATER. The focus of the analysis is the seven individual questions from IPSS and post-operative incontinence symptom index (ISI). RESULTS: 425 men with prostates ranging in size from 20-150 cc were treated with Aquablation Therapy. Outcomes from the seven questions from the IPSS questionnaire are in Figure 1 for prostates <100c, prostates >100cc, prostate anatomy with median lobe, and prostate anatomy without median lobe. Regardless of subgroup, all outcomes are consistent and a significant improvement from baseline. Specifically, improvements in frequency, urgency, and nocturia demonstrate bladder function improvement. Patients entering treatment with severe incontinence, ISI score >4, and regardless of prostate size, showed a reduction in incontinence during patient follow-up. CONCLUSIONS: Aquablation Therapy showed remarkable bladder function improvement following the index procedure. Additionally, men with severe incontinence showed a reduction in incontinence post-procedure. Source of Funding: PROCEPT BioRobotics funded clinical trials © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e4-e5 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Dean Elterman More articles by this author Peter Gilling More articles by this author Claus Roehrborn More articles by this author Neil Barber More articles by this author Vincent Misrai More articles by this author Kevin C. Zorn More articles by this author Naeem Bhojani More articles by this author Alexis E. Te More articles by this author Mitch Humphreys More articles by this author Steven Kaplan More articles by this author Mihir Desai More articles by this author Thorsten Bach More articles by this author Expand All Advertisement Loading ...